Kraig Biocraft Labs
Kraig Biocraft Laboratories, Inc. develops protein-based fibers using recombinant DNA technology for commercial applications in the textile and specialty fiber industries in the United States. Its primary proprietary fiber technology includes natural and engineered variants of spider silk produced in domesticated mulberry silkworms, as well as uses genetically engineered silkworms that produce sp… Read more
Kraig Biocraft Labs (KBLB) - Net Assets
Latest net assets as of September 2025: $-7.96 Million USD
Based on the latest financial reports, Kraig Biocraft Labs (KBLB) has net assets worth $-7.96 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($2.36 Million) and total liabilities ($10.31 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-7.96 Million |
| % of Total Assets | -337.61% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Kraig Biocraft Labs - Net Assets Trend (2009–2024)
This chart illustrates how Kraig Biocraft Labs's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Kraig Biocraft Labs (2009–2024)
The table below shows the annual net assets of Kraig Biocraft Labs from 2009 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $-8.15 Million | -42.80% |
| 2023-12-31 | $-5.71 Million | -62.05% |
| 2022-12-31 | $-3.52 Million | +33.50% |
| 2021-12-31 | $-5.30 Million | +19.44% |
| 2020-12-31 | $-6.57 Million | -22.00% |
| 2019-12-31 | $-5.39 Million | -20.83% |
| 2018-12-31 | $-4.46 Million | -32.09% |
| 2017-12-31 | $-3.38 Million | -42.99% |
| 2016-12-31 | $-2.36 Million | -24.45% |
| 2015-12-31 | $-1.90 Million | -54.73% |
| 2014-12-31 | $-1.23 Million | -2.08% |
| 2013-12-31 | $-1.20 Million | -5.91% |
| 2012-12-31 | $-1.13 Million | -25.17% |
| 2011-12-31 | $-906.00K | -46.37% |
| 2010-12-31 | $-619.00K | +80.50% |
| 2009-12-31 | $-3.17 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Kraig Biocraft Labs's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 3490737400.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $44.94 Million | % |
| Total Equity | $-8.15 Million | 100.00% |
Kraig Biocraft Labs Competitors by Market Cap
The table below lists competitors of Kraig Biocraft Labs ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
ISU Abxis Co. Ltd
KQ:086890
|
$73.80 Million |
|
Molecular Partners AG
PINK:MLLCF
|
$73.81 Million |
|
Pricer AB (publ)
PINK:PCRBF
|
$73.82 Million |
|
TerrAscend Corp.
OTCQX:TSNDF
|
$73.89 Million |
|
Shanghai Jinjiang International Travel Co Ltd
SHG:900929
|
$73.78 Million |
|
Sitowise Group Oyj
HE:SITOWS
|
$73.77 Million |
|
Bank Multiarta Sentosa PT
JK:MASB
|
$73.73 Million |
|
GSD Holding AS
IS:GSDHO
|
$73.70 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Kraig Biocraft Labs's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -5,707,156 to -8,149,621, a change of -2,442,465.
- Net loss of 3,398,939 reduced equity.
- Other factors increased equity by 956,474.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-3.40 Million | -41.71% |
| Other Changes | $956.47K | +11.74% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Kraig Biocraft Labs's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2015-12-31 | $0.00 | $0.09 | x |
| 2016-12-31 | $0.00 | $0.09 | x |
| 2017-12-31 | $0.00 | $0.09 | x |
| 2018-12-31 | $-0.01 | $0.09 | x |
| 2019-12-31 | $-0.01 | $0.09 | x |
| 2020-12-31 | $-0.01 | $0.09 | x |
| 2021-12-31 | $-0.01 | $0.09 | x |
| 2022-12-31 | $0.00 | $0.09 | x |
| 2023-12-31 | $-0.01 | $0.09 | x |
| 2024-12-31 | $-0.01 | $0.09 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Kraig Biocraft Labs utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is below the historical average (0.00%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.23 Million |
| 2015 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.42 Million |
| 2016 | 0.00% | -9648.57% | 0.08x | 0.00x | $-2.84 Million |
| 2017 | 0.00% | -2397.40% | 0.85x | 0.00x | $-2.00 Million |
| 2018 | 0.00% | -291.07% | 5.63x | 0.00x | $-723.05K |
| 2019 | 0.00% | 0.00% | 0.00x | 0.00x | $-2.37 Million |
| 2020 | 0.00% | 0.00% | 0.00x | 0.00x | $-4.31 Million |
| 2021 | 0.00% | 0.00% | 0.00x | 0.00x | $-7.52 Million |
| 2022 | 0.00% | 0.00% | 0.00x | 0.00x | $-3.49 Million |
| 2023 | 0.00% | 0.00% | 0.00x | 0.00x | $-2.46 Million |
| 2024 | 0.00% | 0.00% | 0.00x | 0.00x | $-2.58 Million |
Industry Comparison
This section compares Kraig Biocraft Labs's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $6,152,730,030
- Average return on equity (ROE) among peers: 7.12%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Kraig Biocraft Labs (KBLB) | $-7.96 Million | 0.00% | N/A | $73.78 Million |
| AirBoss of America Corp (ABSSF) | $125.98 Million | 8.11% | 0.98x | $57.06 Million |
| Asia Carbon Industries Inc (ACRB) | $35.57 Million | 18.14% | 0.12x | $0.99 |
| Aimia Inc (AIMFF) | $-294.90 Million | 0.00% | 0.00x | $103.68 Million |
| L'Air Liquide S.A (AIQUF) | $5.54 Billion | 13.10% | 0.99x | $107.70 Billion |
| Akzo Nobel N.V (AKZOF) | $5.64 Billion | 14.71% | 1.46x | $9.73 Billion |
| Albemarle Corp (ALB) | $4.47 Billion | 8.41% | 1.34x | $19.07 Billion |
| ALPEK S.A.B. de C.V (ALPKF) | $45.06 Billion | 14.66% | 1.28x | $214.40 Million |
| Altech Batteries Limited (ALTHF) | $68.56 Million | -5.13% | 0.13x | $27.89 Million |
| Arcadium Lithium plc (ALTM) | $795.40 Million | 0.08% | 0.51x | $6.26 Billion |
| Alto Ingredients Inc (ALTO) | $94.90 Million | -0.82% | 1.54x | $212.84 Million |